Panel Discussion: Comparing the Benefits & Limitations of a ‘Fast In, Fast Out’ Approach

• Discussing the impact of small format conjugates on PK profiles
• Discussing how linker selection can impact the overall performance of small format conjugates
• Highlighting their potential vs their pitfalls for tumor types which are resistant to ADCs

Speakers:

Mahendra Deonarain

Chief Executive, Science & Operating Officer

Antikor

Joe nabhan

cso

K2B Therapeutics Inc.